Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 1
2015 1
2017 2
2018 8
2019 9
2020 4
2021 8
2022 15
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Pfeffer MR, Levin D, Mueller AC, Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Chuong MD. Parikh PJ, et al. Among authors: henke le. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):799-808. doi: 10.1016/j.ijrobp.2023.05.023. Epub 2023 May 19. Int J Radiat Oncol Biol Phys. 2023. PMID: 37210048 Free article. Clinical Trial.
The Use of MR-Guided Radiation Therapy for Liver Cancer.
Prime S, Schiff JP, Hosni A, Stanescu T, Dawson LA, Henke LE. Prime S, et al. Among authors: henke le. Semin Radiat Oncol. 2024 Jan;34(1):36-44. doi: 10.1016/j.semradonc.2023.10.006. Semin Radiat Oncol. 2024. PMID: 38105091 Review.
Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program.
Price AT, Schiff JP, Laugeman E, Maraghechi B, Schmidt M, Zhu T, Reynoso F, Hao Y, Kim T, Morris E, Zhao X, Hugo GD, Vlacich G, DeSelm CJ, Samson PP, Baumann BC, Badiyan SN, Robinson CG, Kim H, Henke LE. Price AT, et al. Among authors: henke le. Clin Transl Radiat Oncol. 2023 Jul 22;42:100661. doi: 10.1016/j.ctro.2023.100661. eCollection 2023 Sep. Clin Transl Radiat Oncol. 2023. PMID: 37529627 Free PMC article.
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD, Clark MA, Henke LE, Kishan AU, Portelance L, Parikh PJ, Bassetti MF, Nagar H, Rosenberg SA, Mehta MP, Refaat T, Rineer JM, Smith A, Seung S, Zaki BI, Fuss M, Mak RH. Chuong MD, et al. Among authors: henke le. Clin Transl Radiat Oncol. 2022 Nov 22;38:161-168. doi: 10.1016/j.ctro.2022.11.013. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36466748 Free PMC article.
Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
Chin RI, Otegbeye EE, Kang KH, Chang SH, McHenry S, Roy A, Chapman WC Jr, Henke LE, Badiyan SN, Pedersen K, Tan BR, Glasgow SC, Mutch MG, Samson PP, Kim H. Chin RI, et al. Among authors: henke le. JAMA Netw Open. 2022 Feb 1;5(2):e2146312. doi: 10.1001/jamanetworkopen.2021.46312. JAMA Netw Open. 2022. PMID: 35103791 Free PMC article.
54 results